Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Top 5 Things to Know In the Market on Tuesday

Published 2016-04-05, 05:58 a/m
© Reuters.  Top 5 Things to Know Today In Financial Markets
USD/JPY
-
DE40
-
AGN
-
PFE
-
AGN_pa
-
LCO
-
CL
-
1YMU24
-

Investing.com - Here are the top five things you need to know in financial markets on Tuesday, April 5:

1. Dollar tumbles to 17-month low against the yen

The dollar fell to its lowest level in 17 months against the safe-haven yen on Tuesday, prompting speculation over a possible intervention to halt the appreciation of the Japanese currency.

USD/JPY hit lows of 110.30, the weakest level since October 31, 2014 and was last at 110.38 by 9:56GMT, or 5:56AM ET, off 0.86% for the day. The pair has fallen more than 8% so far this year.

The yen’s gains fueled speculation over how much higher the currency can climb before Japanese officials act to weaken the currency.

2. Oil sinks to 4-week lows

Oil prices extended losses from the prior session on Tuesday, falling to fresh four-week lows as investors are starting to doubt whether there will be an agreement between top oil producers of a coordinated freeze at a meeting in Doha, set to take place on April 17.

U.S. crude was down 24 cents, or 0.67%, to $35.46 a barrel, while Brent shed 31 cents, or 0.82%, at $37.38.

3. Global stock markets slammed

European stocks were deep in negative territory on Tuesday, with Germany’s DAX down more than 2.5%, as a decline in oil prices weighed on investor sentiment and dragged down resource companies.

Meanwhile, U.S. stock futures pointed to a sharply lower open, with the Dow futures falling more than 120 points, amid mixed messages from Federal Reserve policymakers on the outlook for U.S. interest rate rises and as market players awaited service sector data due later in the session.

Earlier, markets in Asia closed mostly lower following losses in U.S. equities overnight amid fresh declines in oil prices.

4. Allergan (NYSE:AGN_pa) shares plummet 20% in pre-market

Shares of Allergan Plc (NYSE:AGN) plunged 22.5% to $215.00 ahead of the opening bell, following news of the U.S. Treasury Department's new steps to curb tax-avoiding inversion deals in which a U.S. company reincorporates overseas after the purchase of a foreign company.

Dublin-based Allergan has agreed to be bought by Pfizer (NYSE:PFE) in the biggest inversion deal ever. Shares of Pfizer were up 2.9% at $31.62 in pre-market trading.

5. Central bank roundup: India, Australia

The Reserve Bank of India cut its benchmark interest rate by 25 basis points to 6.5%, the lowest since January 2011, in a widely anticipated move. The RBI hinted at another rate cut later this year if inflation trends stay benign.

Elsewhere, Australia's central bank left interest rates at a record-low 2.0%, where they have been for nearly a year, citing evidence of continued growth at home despite an unhelpful rise in the local dollar.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.